IPO at First North
Stayble Therapeutics AB aim to list the Company’s shares on Nasdaq First North Growth Market. In connection with the listing, the Company carries out a new unit issue of approximately SEK 35 million, before deduction of transaction costs, where each unit consists of one share and one warrant free of charge.
The full terms and conditions for the Offering is available in a prospectus (only in Swedish), see below.
Nasdaq Stockholm AB has approved Stayble’s application for admission of trading of the Company’s shares and warrants on Nasdaq First North, provided that the Company meets the conditions in Nasdaq First North’s rulebook such as distribution requirements, no later than the first day of trading which is expected at March 9, 2020.